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Summary
Objectives: This review is focused on the inﬂuence of oxygen and derived reactive species on chondrocytes aging, metabolic function and
chondrogenic phenotype.
Methods: A systematic computer-aided search of the Medline database.
Results: Articular cartilage is an avascular tissue, and consequently oxygen supply is reduced. Although the basal metabolic functions of the
cells are well adapted to hypoxia, the chondrocyte phenotype seems to be oxygen sensitive. In vitro, hypoxia promotes the expression of the
chondrogenic phenotype and cartilage-speciﬁc matrix formation, indicating that oxygen tension is probably a key parameter in chondrocyte
culture, and particularly in the context of tissue engineering and stem cells transplantation. Besides the inﬂuence of oxygen itself, reactive
oxygen species (ROS) play a crucial role in the regulation of a number of basic chondrocyte activities such as cell activation, proliferation and
matrix remodeling. However, when ROS production exceeds the antioxidant capacities of the cell, an ‘‘oxidative stress’’ occurs leading to
structural and functional cartilage damages like cell death and matrix degradation.
Conclusions: This paper is an overview of the in vitro and in vivo studies published on the inﬂuence of oxygen and derived reactive species on
chondrocyte aging, metabolic function, and the chondrogenic phenotype. It shows, that oxygen and ROS play a crucial role in the control of
cartilage homeostasis and that at this time, the exact role of ‘‘oxidative stress’’ in cartilage degradation still remains questionable.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
Osteoarthritis (OA) is the most common disabling condition
of man in the western world. It is not a single disease entity,
but represents a disease group with rather different
underlying pathophysiological mechanisms. OA is a disease
of a whole organ system, the joint, including the cartilage,
the subchondral bone, the synovial capsule and membrane
and the periarticular (connective and muscular) tissues. The
metabolic and structural changes in the articular cartilage
are thought to play a leading role in the initiation and the
progression of the disease process.
Articular cartilage is a highly specialized and uniquely
designed biomaterial that forms the smooth, gliding surface
of the diarthrodial joints. It consists mostly of an avascular,
aneural and alymphatic matrix which is synthesized by the
sparsely distributed resident cells e the chondrocytes1. The
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(mainly type II collagen) and proteoglycans (mainly aggre-
cans) that are responsible for the functional properties of
cartilage. The adult articular cartilage is in principle working
by the biomechanical properties of its extracellular matrix,
and the destruction of the extracellular matrix of articular
cartilage is the hallmark of OA. However, the chondrocytes
play a decisive role as they are solely responsible for matrix
turnover and maintenance. An imbalance of the anabolice
catabolic activity is thought to be one essential feature of
OA cartilage degeneration. This includes a focal suppres-
sion of anabolic activity2 as well as a signiﬁcant increase in
catabolic genes expression, in particular of matrix metal-
loproteinases (MMP) such as collagenase-3 (MMP-13) and
gelatinase A (MMP-2)3e5. However, many other relevant
cellular processes are going on at the same time and the
overall cellular reaction patterns appear to be very complex.
As adult articular cartilage is an avascular and, thus, per se
hypoxic tissue, the cells must be well adapted to this. The
implications of this hypoxic environment are hardly un-
derstood on the molecular level. Additionally, the role of
changes in oxygen (O2) levels during the process of
cartilage degeneration seems to be of great interest. Oxygen
can also be processed into the so-called reactive oxygen
species (ROS). ROS are molecules like hydrogen peroxide43
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), radicals like
hydroxyl radical (cOH) or the superoxide anion (O2
c) which
is an ion and a radical at the same time. ROS are involved,
both, in intracellular signaling and, thus, cell physiology, but
also in cellular destruction as pointed out below. This review
intends to give a broad overview of the role of O2 and ROS in
cartilage homeostasis and degradation, in particular with
respect to the development of OA joint disease.
Methods
This review results of a systematic computer-aided search
of the Medline database for the period 1995 through January
2005 [key words: oxygen, free radicals, reactive oxygen
species, antioxidants, chondrocytes, cartilage, osteoarthri-
tis, arthritis, aging]. Three reviewers (YH, BD, TA) have
selected the in vitro and in vivo studies included in this
review. BD has reviewed and interpreted studies on O2, YH
on antioxidants, and YH and TA on ROS. The introduction
and discussion sections have been collectively written.
Results
LOW OXYGEN TENSION AND CARTILAGE METABOLISM
Articular cartilage is an avascular tissue and its nutrition
is mainly supplied by the synovial ﬂuid, where O2 tension is
about 7%6. As a consequence, the O2 tension has been
described to be lower than 8% in cartilage tissue in vivo7.
Subsequently, chondrocytes have to be adapted to a low
O2 tension environment
8. Lee and Urban9 observed that
chondrocytes produced their adenosine triphosphate (ATP)
mostly by substrate-level phosphorylation in glycolysis.
However, O2 tensions below 1% inhibited both, glucose
uptake and lactate production as well as cellular ribonucleic
acid (RNA) synthesis10. This indicates that chondrocytes
need at least some O2 for their basal metabolic activity.
Indeed, chondrocytes have mitochondria. Stockwell11
showed that the density of mitochondria in chondrocytes
was higher in the superﬁcial zones of articular cartilage from
dogs than in the deeper zones, where the O2 tension might
be as low as 1%. Thus, cartilage has the ability to call up on
an aerobic metabolism under higher O2 tension condi-
tions12. Nevertheless, Otte13 found the so-called ‘‘Crabtree’’
effect in chondrocytes, where the O2 consumption is
inhibited by increased glucose concentrations. This sup-
ports the idea that a chondrocyte is mostly an anaerobic
working cell. In addition, Otte showed that the O2
consumption, which is very low in chondrocytes in
comparison to other cells, can only be inhibited about
80e90% by potassium cyanide, indicating that some O2
must be metabolized by non-mitochondrial oxidases in the
cells. One important challenge in the future would be to ﬁnd
out what these oxidases are needed for.
But how does O2 modulate chondrocyte activities?
Oxygen-dependent signaling pathways in chondrocytes
are still poorly understood. There is evidence that human
and bovine articular chondrocytes, murine epiphyseal
chondrocytes, as well as chondrosarcoma cells express
hypoxia-inducible factor-1a (HIF-1a)14e18. It might be
suggested, that chondrocytes use the same O2-sensing
pathways as other mammalian cells, where in normoxic
(21% O2) conditions HIF-1a is hydroxylated by an O2-
dependent mechanism19. This hydroxylation is catalyzed by
a prolyl hydroxylase which needs vitamin C and Fe2C for its
activity. The hydroxylation allows binding of HIF-1a to thevon Hippel-Lindau tumor suppressor protein and this
binding triggers subsequent enzymatic degradation. In
hypoxia (!5%), HIF-1a does not get hydroxylated and
cannot be degraded. It translocates into the nucleus, forms
a heterodimer with HIF-1b, which is constitutively ex-
pressed, and activates hypoxia-inducible target genes by
binding to HIF-1 binding sites in hypoxia response elements
of the DNA (Fig. 1). Most of these steps have not been
shown in cartilage tissue so far, but in other tissues.
However, hypoxia has recently been demonstrated to
increase matrix synthesis of epiphyseal chondrocytes14,
and to induce vascular endothelial growth factor (VEGF)
expression in chondrosarcoma cells and normal chondro-
cytes through HIF-1a activity15,16. HIF-1a also regulates
glycolysis since deletion of this molecule disabled murine
chondrocytes to maintain normal ATP levels under hypoxic
conditions14. For that reason it seems reasonable to believe
that HIF-1a plays a crucial role in O2-dependent signaling
pathways in articular chondrocytes.
Most of the recent studies investigate the inﬂuenceofO2on
the deposition of extracellular matrix components. All these
studies are often discussed in the context of tissue
engineering aspects20e27. Mostly low O2 tension (5%)
increases collagen type II synthesis or glycosaminoglycans
(GAG) synthesis in the different systems22e26 (Table I).
Further, low O2 tension (8%) stabilizes the chondrogenic
phenotype27. In low O2 tension (5%), and independent of the
type of culture system, bovine chondrocytes show a lower
collagen type I expression and a higher collagen type II
expression compared to normoxia23,25. It was also demon-
strated that low O2 tension (5%) stimulates the redifferentia-
tion of dedifferentiated adult humanandbovine chondrocytes
in three-dimensional culture systems like alginate25,28,29,
pellet cultures30, or on collagen I/III membranes23.
Fig. 1. HIF-1a oxygen-sensing pathways. In high oxygen tension,
HIF-1a is hydroxylated allowing its binding to the von Hippel-Lindau
(pVHL) tumor suppressor protein and subsequent enzymatic
degradation. This reaction is catalyzed by prolyl hydroxylases
(PHD). In low oxygen tension, HIF-1a cannot be degraded,
translocates into the nucleus, forms a heterodimer with HIF-1b,
which is constitutively expressed, and activates hypoxia-inducible
target genes by binding to HIF-1 binding sites in hypoxia response
elements (HRE) of the DNA (modiﬁed from Ref. 128).
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Data from the literature about the influence of low oxygen tension vs atmospheric oxygen conditions on matrix synthesis of primary and
dedifferentiated articular chondrocytes (AC) or other chondrocytes in different culture systems
Species Type of culture Low vs high
oxygen tension
Effect on ECM Reference
Primary Bovine Articular cartilage
explants
6%/24% Sulfate incorporation Y 21
Bovine AC in porous
polylactic acid
constructs
5%/20% GAG [ 22
Collagen C/
Bovine Alginate and
collagen I/III
membrane cultures
with AC
5%/20% Ratio of protein and
mRNA Coll II/Coll I [
23
Bovine AC monolayers 5%/20% Coll II [ 24
Coll IX [
Coll I Y
Bovine AC in alginate 5%/20% Coll II [ 25
Human OA AC on collagen
I/III membranes
5%/20% Proline and sulfate
incorporation [
26
Dedifferentiated Bovine AC on collagen
I/III membranes
5%/20% Coll II [ 23
Bovine Cells in alginate 5%/20% Coll II [ 25
Coll IX [
Coll I Y
Bovine AC in alginate 5%/20% mRNA Coll II [ 28
mRNA aggrecan [
Human AC in alginate 5%/20% mRNA Coll II [ 29
mRNA aggrecan [
Human Nasal cells in pellet
culture
5%/20% GAG [ 30
Coll II [
1%/20% GAG [[
Coll II [One particular aspect is the inﬂuence of O2 tension on
chondrogenesis. Forty years ago, it was suggested that low
O2 tension could stimulate mesenchymal stem cells to
differentiate into chondrocytes31e33. More recently, it was
demonstrated that in vitro low O2 tension promotes osteo-
genesis34. Rat mesenchymal stem cells express more
markers of osteogenesis, including alkaline phosphatase
activity, calcium content and von Kossa staining in low O2
tension (5%) than in normoxia (21%). Further, mesenchy-
mal cells cultured in low O2 tension produced more bone
than cells cultured in normoxia when harvested and loaded
in porous ceramic cubes and implanted in host animals.
Recently, another study with adherent bone marrow cells
from bovine tissue showed that low O2 tension (5%) alone
might support, but does not induce chondrogenesis26. For
that reason the inﬂuence of O2 on chondrogenesis still
remains unclear.
Recently, two papers have reported the inﬂuence of
hypoxic conditions on bovine chondrocyte responses to
interleukin (IL)-1b, one of the most active catabolic
cytokines in OA35,36. They reported that IL-1b-induced
DNA binding of nuclear factor-kappaB (NF-kB) and
activating protein (AP)-1 was signiﬁcantly higher in low O2
tension (5% O2) than in normoxia (21% O2) and greater
activation of MAPKs was also observed with IL-1b
treatment in hypoxia compared with normoxia. Steady-state
levels of type II collagen and aggrecan core protein
messenger RNA (mRNA) were decreased by IL-1b in both
5 and 21% O2. MMP-1 and MMP-3 mRNA were increased
by IL-1b in low O2 tension and in normoxia, whereas MMP-9
mRNA was dramatically decreased by IL-1b only in low O2
tension. One of the most striking ﬁndings of these studieswas the greater stimulating effect of IL-1b on cNO pro-
duction observed in low O2 tension, which was much higher
than in normoxia. In contrast, prostaglandin (PG) E2
production was not induced by IL-1b in low O2 tension,
but highly increased in normoxia. These studies indicate
that the response of chondrocytes to IL-1b, and probably to
other cytokines, is highly dependent on O2 tension, and that
some results previously obtained in normoxic cultures
should be revisited to better understand the mechanisms
of cartilage degradation in joint diseases.
OXIDATIVE STRESS IN CARTILAGE DEGRADATION
In some physiological and pathological circumstances,
O2 may be transformed into ROS, and then be involved in
the control of various aspects of biological processes
including cell activation, proliferation and death. Especially,
low levels of ROS have been reported to act as one of the
different intracellular second messenger molecules in-
volved in the regulation of the expression of a wide variety
of gene products, including cytokines, MMPs, adhesion
molecules and matrix components37,38. Elevated produc-
tion of ROS and/or depletion of antioxidants have been
observed in a variety of pathological conditions, including
inﬂammatory joint diseases. The intracellular and extracel-
lular redox state may be causally implicated in the
progression of these diseases (see review39,40). When the
imbalance between oxidants and antioxidants is large
enough to induce cellular and/or tissular structural and/or
functional changes, the situation is called ‘‘oxidative stress’’
and is considered as an abnormal catabolic event. At this
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pathological circumstances remains incomplete. The fol-
lowing sections cover the recent ﬁndings on the redox state
of pathological chondrocytes and on the role of oxidative
stress in cartilage degradation.
ROS synthesis and formation
The overproduction of ROS in pathological cartilage has
been indirectly evidenced by the accumulation of lipid
peroxidation products and nitrotyrosine in situ41,42. Re-
cently, Henrotin et al. have found elevated nitrated type II
collagen peptides in sera of patients with OA, suggesting
the formation of ONOO in OA cartilage43. Chondrocytes
produce basically cNO and O2
c that generate derivative
radicals including ONOO and H2O2. In the presence of
iron (Fe2C), cOH is formed through the metal-catalyzed
HabereWeiss reaction (Fig. 2). cNO is synthesized by NO
synthase (NOS) enzymes. Of the three NOS isoforms, two
are constitutively expressed, endothelial NOS (eNOS,
NOS3) and neuronal NOS (nNOS, NOS1), and one is
inducible (iNOS, NOS2). Chondrocytes express both eNOS
and iNOS44. The inducible form is regulated at the gene
level by a variety of mechanical and chemical factors. In
vitro, cNO production is stimulated mechanically by shear
stress, static and intermittent compression, and by media-
tors like IL-1b and IL-17, tumor necrosis factor (TNF)-a,
interferon (IFN)g and lipopolysacharrides (LPS). cNO pro-
duction is inhibited by transforming growth factors (TGF)-b,
IL-4, IL-6, IL-10, IL-13 and oncostatin (OSM)44e51. Besides
mechanical stress and cytokine overproduction, accumula-
tion of ﬁbronectin fragments in OA cartilage is an important
feature in cartilage degradation. The amino (NH2)-terminal
heparin-binding ﬁbronectin fragment has been shown to
stimulate cNO production in association with iNOS induction
in human chondrocytes in monolayer. The COOH-terminal
heparin-binding ﬁbronectin fragment has been shown to
stimulate cNO production through CD44 receptor activation
in rheumatoid arthritis (RA) cartilage explants52. Whether
other ﬁbronectin fragments can activate cNO induction in
Fig. 2. Schematic representation of the main sources of ROS in
chondrocytes. NOSZ nitric oxide synthase; MPOZmyeloperox-
idase, NO2
Z nitrite; cNO2Z nitrosyl radical; ONOO
Z peroxyni-
trite; cOHZ hydroxyl radical; O2
cZ superoxide anions; H2O2Z
hydrogen peroxide; HOCLZ hypochlorite acid.articular chondrocytes and whether OA chondrocytes are
more sensitive to these fragments remains unknown.
O2
c formation is catalyzed by a nicotinamide dinucleotide
phosphate (NADPH) oxidase multicomponent enzyme
system which consists of essentially two membrane bound
components: a ﬂavocytochrome, formed by two peptides of
22 and 91 kDa (p22Phox and gp91phox, respectively) and
a regulatory peptide named Rap1A. Activation of the
oxidase requires the translocation to the membrane of at
least three further cytosolic components of 40, 47 and
67 kDa (p40phox, p47phox, and p67phox, respectively).
Articular chondrocytes express cell-speciﬁc components of
the NADPHoxidase complex such as p22phox, p40phox,
p47phox, p61phox and gp91phox53e55. Recently, O2
c pro-
duction by TNFa-stimulated human chondrocytes has been
evidenced by electronic spin resonance using 5,5-demeth-
yl-1pyrroline N-oxide (DMPO) as spin trapper56. In vitro,
cyclic stretch generated by a vacuum-operated instrument,
enhanced intracellular chemiluminescence in a magnitude
dependent manner57. This effect was completely
abolished by the addition of superoxide dismutase
(SOD) suggesting that O2
c is responsible for this stretch-
enhanced chemiluminescence. In cultured bovine articular
chondrocytes, oxidized low-density lipoprotein (ox-LDL),
but not native LDL, increased the production of intra-
cellular ROS through its binding to a lectin-like ox-LDL
receptor-1 (LOX-1). This effect is suppressed by the
addition of diphenyleneiodonium (DPI), a well-known
inhibitor of ﬂavoproteins, strongly suggesting the involve-
ment of NADPHoxidase activation in ROS production58.
Using a chromatographic method (measurement of ethy-
lene production from g-methiol-keto-butyric acid after cOH
attack), Henrotin et al.59 have demonstrated that phorbol
12-myristate-acetate (PMA) and anoxia-reoxygenation
cycles increased cOH production. Hydroxyl radical may be
also measured by electron spin resonance as an alpha-
hydroxyethyl spin trapped adduct of 4-pyridyl l-oxide N-tert-
butylnitrone (4-POBN). IL-1b and TNFa enhanced cOH
formation in PMA-treated chondrocytes60. The presence of
myeloperoxidase (MPO) remains hypothetical (Fig. 2).
Cartilage antioxidant states
To prevent toxicity by ROS, chondrocytes possess a well-
coordinated antioxidant enzyme system formed by SOD,
catalase and glutathione peroxidase (GPX). SOD are
metalloproteins, which transform O2
c into H2O2 and O2. In
human, there are three forms of SOD: cytosolic Cu/Zn SOD,
mitochondrial Mn SOD, and extracellular SOD (EC-SOD).
SOD play a critical but limited role in detoxifying ROS, as
H2O2 can cause oxidative stress if the levels of the H2O2
detoxiﬁcation enzymes are ineffective or depleted. Catalase
and GPX are widely investigated as H2O2-scavenging
enzymes. Human chondrocytes constitutively express
catalase, GPX and Cu/Zn and Mn SOD61. Borsiczky
et al.62 have reported an increase in SOD activity in pig
chondrocytes exposed to activated neutrophils or H2O2. In
vitro, cyclic tensile stretch simultaneously increased both
ROS and SOD activity and caused depolymerization of
hyaluronan indicating that ROS production exceeded
environmental antioxidant capacities57. Another enzyme
important in this enzymatic antioxidant system is glutathi-
one reductase, which regenerates reduced glutahione
(GSH) from oxidized glutahione (GSSH) at the expense
of NADPH. The exposure of human chondrocytes to
3-morpholinosydninimine (SIN-1), a compound generating
647Osteoarthritis and Cartilage Vol. 13, No. 8both cNO and O2
c, results in a decreased activity of
glutathione reductase63.
Recently, a novel family of peroxidases, the peroxiredox-
ins (PRDX), was identiﬁed in many living organisms. Six
isoforms of PRDX have been described in mammals, all of
which participate directly in eliminating H2O2 and neutral-
izing other oxidizing chemicals. Normal human cartilage
constitutively expresses PRDX564e66. Morever, PRDX5 is
found to be elevated in OA cartilage and its expression is
up-regulated by IL-1 and TNFa. This IL-1/TNF stimulating
effect is fully inhibited by catalase, indicating that H2O2 is an
important mediator for the cytokine-induced PDRX5 up-
regulation67.
Oxidative degradation of cartilage
Cartilage degradation, which is likely to be driven by
biomechanical factors, results in an imbalance between
catabolic and anabolic activity. Metalloproteinases and
ROS are the two main actors of matrix component
degradation. They have been found to be overproduced in
OA cartilage and synovium (see below). ROS may directly
oxidize nucleic acids, transcriptional factors, membrane
phospholipids, intracellular and extracellular components
leading to impaired biological activity, cell death and matrix
components breakdown38,39,68e71.
Cell death. Since adult cartilage lacks a mechanism to
replace damaged or dead cells, chondrocyte depletion is
a largely investigated feature of cartilage degeneration.
However, some of the reported studies used cell death
assays that do not distinguish between the various cell
death modalities since they measure variables common to
different cell death processes. Application of a single
technique cannot be considered as sufﬁcient to deﬁnitively
distinguish between apoptosis and necrosis and a combi-
nation of methods measuring morphological and mecha-
nistic cell death parameters are required. For this reason,
the term ‘‘cell death’’ will be preferred to ‘‘apoptosis’’ or
‘‘necrosis’’ when reported cell death was investigated by
a single technique (see review72). Increased chondrocyte
death has been noted with aging63, mechanical damage73
and in OA tissue74.
cNO has long been considered as the primary inducer of
cell death, mediated by caspase-3 and tyrosine kinase
activation75. However, the concept that cNO by itself is
a promoter of cell death remains questionable. Some recent
papers have suggested that cNO toxicity is modulated by
other ROS. IL-1b, a potent stimulator of cNO production in
chondrocytes did not cause cell death76, whereas in the
presence of an oxygen radical scavenger, hypoploid and
DNA fragmentation were observed. These data suggest
that the proapoptotic effect of cNO could be blocked by other
ROS. Inversely, other studies have reported that cNO
mediated cell death required generation of other ROS, with
cNO itself not being toxic to cells77,78. Recently, it was
observed that compounds that only release cNO, even at
high quantities, did not cause cell death whereas SIN-1
induced chondrocyte death suggesting a role for O2
c or
ONOO in this process63. This is supported by another
recent ﬁnding by Kurz et al.79 showing that mechanically
induced cell death can be prevented by a preincubation with
a cell-permeable SOD mimetic, which has been shown to
eliminate O2
c and H2O2 in other in vitro systems. Addition-
ally, static compression of articular cartilage might inducerelease of O2
c and cNO under certain conditions80. In
conclusion, it might be suggested that O2
c plays an
important role in chondrocyte cell death.
In contrast, Del Carlo and Loeser77 have proposed that
cNO could be anti-apoptotic, primarily when the intracellular
antioxidant level was very low. In bovine cultured chon-
drocytes, cNO also reduced H2O2-induced apoptosis, as
detected by annexin V and DNA fragmentation80. HOCl
caused rapid deletion of chondrocytes ATP and GSH as
well as reduced chondrocytes viability. However, when
HOCl was added in the presence of physiological concen-
trations of NO2
, the latter was oxidized to NO3
, and HOCl-
induced cytotoxicity was inhibited. This is presumably
because HOCl is removed by reacting with NO2
 to give
nitryl chloride (NO2Cl). NO2Cl is less damaging for cells
than HOCl81. These data suggest that NO2
 accumulation at
chronic inﬂammatory sites, where both HOCl and cNO are
overproduced, may be cytoprotective against damage
caused by HOCl.
Matrix degradation. Evidence of the involvement of ROS in
cartilage matrix degradation comes from animal models
showing that ROS scavengers or ROS production inhibitors
slow-down cartilage loss82e84. ROS may act at different
levels of the cartilage degradation process, by inhibiting
matrix formation and/or by inducing oxidative extracellular
matrix degradation and expression of matrix-degrading
enzymes. Recently, it has been reported that ATP depletion
and impairment of mitochondrial electron transport in
chondrocytes were associated with cartilage degradation
and mineralization in human and animal models85,86. ROS
suppress mitochondrial oxidative phosphorylation and ATP
formation in cultured chondrocytes, two mechanisms that
are linked to a decrease of collagen and proteoglycan
synthesis87.
Resistance of chondrocytes to stimulation by growth
factors such as insulin-like growth factor (IGF)-1, that
promote matrix formation, largely contributes to create an
imbalance between anabolic and catabolic events in
degenerative cartilage. Increased production of cytokines
including IL-1b and TNFa also appears to contribute to this
imbalance in an autocrine/paracrine manner. IL-1b and
TNFa have been shown both, to inhibit synthesis of matrix
components and to stimulate MMP production88,89. Since it
has been demonstrated that iNOS knockout mice with
zymosan induced arthritis retain sensitivity to IGF-1, cNO
was suspected to be responsible for the insensitivity of OA
chondrocytes to IGF-190. cNO generated by S-nitroso-N-
acetyl-D,L-penicillamine (SNAP) or endogenously induced
by IL-1b, inhibited in a dose-dependent and reversible
manner IGF-1 stimulated proteoglycan synthesis91,92. A
similar effect was obtained with SIN-1, suggesting that
ONOO could be the effective ROS in this mechanism93.
ROS are also involved in the regulation of IL-1 effects
mediated by NF-kB. NF-kB up-regulates genes, including
MMP, that are involved in cartilage degradation. Recently, it
was demonstrated that cNO, most probably via ONOO,
sustained nuclear translocation of P65 subunit in cytokine-
activated chondrocytes and thereby provided a persistent
‘‘on signal’’ to NF-kB dependent gene transcription37. In-
terestingly, ox-LDL dose-dependently increased NF-kB58,
indicating that ox-LDL not only acts by oxidizing pericellular
matrix69, but also by activating a transcription factor involved
in the expression of catabolic genes. From the different in
vitro and animal studies, we can conclude that in pathological
circumstances, ROS contribute to cartilage degradation by
648 Y. Henrotin et al.: Oxygen and reactive oxygen species in cartilage degradationdirectly degrading matrix components, by sustaining the
activity of catabolic cytokines and by reducing cartilage repair
capacities. Altogether, these observations support the
concept of antioxidant therapy in rheumatic diseases and it
might also decrease the progression of OA (see below).
AGING AND SENESCENCE OF CHONDROCYTES e IMPLICATION
OF CONTINUED OXIDATIVE STRESS
The cellular behavior during the OA disease process is
rather pleiomorphic94. They may proliferate and increase
their synthetic activities in order to compensate for cartilage
loss. They also may differentiate into hypertrophic cells and
induce matrix mineralization or adopt pre-apoptotic pheno-
type95,96. However, these processes appear only partly
coordinated and there is considerable heterogeneity in the
cellular gene pattern2. Thus, many of these alterations are
on the one hand ‘‘deterministic’’ (i.e., coordinated) reactions
of the chondrocytes to various stimuli including matrix
alterations, differences in loading or exposure to cytokines
and growth factors. On the other hand, a ‘‘stochastic’’ (i.e.,
uncoordinated) chondrocyte behavior is observable, that
might reﬂect a deeper cellular derangement (Fig. 3)97. In
this respect, oxidative damage to various essential cellular
constituents plays an important role.
Cartilage has neither external cell supply (via the
vasculature) nor any sort of germinal cell layer (as do
e.g., epithelial cells) in order to compensate for cell loss due
to necrosis, apoptosis or other cellular mechanisms.
Although chondrocytes might divide in particular circum-
stances, adult articular cartilage is usually classiﬁed as
a post-mitotic tissue with insigniﬁcant cellular turno-
ver74,98e100. As outlined above, ROS are relevant in many
respects for the chondrocytes, both as (physiological)
intracellular signaling molecules as well as molecules,
which are very detrimental. The OA chondrocytes are likely
to have signiﬁcant DNA-damage74,101e103 and should lead
to apoptotic cell death. However, apoptosis appears to be
rather rare in OA cartilage. Instead, the chondrocytes might
stay in a pre-apoptotic phenotype104 with a discoordinated
pattern of gene expression. In this respect, Aigner et al.
have recently demonstrated that GTPase and RhoB, which
are usually responsible for cell removal following unaccept-
able cell damage, are signiﬁcantly down-regulated in OAchondrocytes105. Thus, RhoB is thought to be essentially
involved in the induction of apoptosis following signiﬁcant
DNA-damage. The suppression of RhoB allows the escape
from the apoptotic suicide program due to DNA-damage106.
In general, cellular aging is associated with a number of
changes in gene expression that may undermine the ability
of cells to maintain tissue homeostasis. Thus, the cells tend
to loose their proliferative activity after certain doublings in
culture (‘‘intrinsic’’ replicative senescence) due to telomere
shortening107. This process certainly does not play a role in
a post-mitotic tissue like articular cartilage. Alternatively,
cellular senescence might be provoked by various cellular
events such as oxidative damage to DNA or other cell
components. This model of senescence may be called
‘‘extrinsic’’ or stress-induced senescence. This is in
particular true for post-mitotic tissues, in which damaged
proteins, lipids and DNA accumulate over time. For
example, mutagenic 8-oxoguanine108, lipid oxidation prod-
ucts69 and nitrotyrosine109 accumulate in cell and disturb
normal cellular functions. All these changes are usually of
only limited relevance for the cell during phases of
proliferative activity. Indeed, a large portion of these
molecules is re-synthesized, but this ‘‘recreation’’ procedure
does not occur in post-mitotic cells, leading to an
accumulation of altered molecules. Thus, this telomere-
independent aging of cells gradually damages cellular
functions until the cells can no longer fulﬁll their essential
tasks within the tissue (e.g., matrix anabolism and
maintenance).
Oxidative stress-induced cell alterations are also docu-
mented by the age-related degeneration of mitochondria
leading to a leakage of oxidative chain and signiﬁcant
damage to the mitochondrial genome110e114. This results in
increased free radicals production, and consequently to
increased damage to mitochondrial DNA. The mitochondrial
genome is particularly exposed to oxidative damage
because it is located aside the oxidative chain, not
protected by a nuclear membrane. Further, DNA-repair in
mitochondria is rather limited compared to the genome
repair capacity of the cells115. It remains unclear, whether
this fully applies also to chondrocytes which show a low O2
consumption and might, thus, be less prone to oxidative
damage to mitochondrial DNA compared to other cells.un-coordinated
matrix destruction 
coordinated processes 
mediators
(growth factors, cytokines)
functional dysfunctional
load
Fig. 3. Chondrocytes in OA cartilage are exposed to load, matrix destruction and mediators of various origins, all of which cause a structured
reaction pattern, which might be either helpful for the tissue (e.g., anabolism) or even detrimental (e.g., cell death etc.). However, besides
these structured processes, presumably a chaotic reaction pattern also occurs reﬂected in the microheterogeneity of cellular reaction pattern
found in OA cartilage.
649Osteoarthritis and Cartilage Vol. 13, No. 8ANTIOXIDANTS SUPPLEMENTATION AND CARTILAGE
DEGRADATION
Several authors have reported depressed antioxidant
levels in the plasma or serum of RA patients. Further, there
are evidences that a low antioxidant status is associated
with a higher risk of developing RA, disease activity and
inﬂammatory processes116e121. In contrast, epidemiological
studies examining the role of antioxidants, especially
tocopherols, in human OA are few and contradictory.
Recently, a caseecontrol study including 200 people with
radiographic knee OA (KellgreneLawrence R 2) and 200
controls (KellgreneLawrenceZ 0) has reported that per-
sons with radiographic knee OA had lower mean values for
a:g tocopherol ratio and higher mean values for d and g
tocopherol122. Further, persons in the highest tertile of the
a:g tocopherol ratio had half the odds of radiographic knee
OA. There are conﬂicting results that vitamin E (a-
tocopherol) relieves symptoms or prevents OA occurrence
or progression121e125. Several methodologically limited
clinical trials have suggested that a-tocopherol supplemen-
tation might be superior to placebo and equal in effective-
ness to anti-inﬂammatory medication in relieving knee OA
symptoms120,121. In contrast, other studies have failed to
show an effect123,124.
In the Framingham OA study, McAlindon and collabo-
rators122 reported that intakes of vitamin C, b-carotene, and
vitamin E were associated with a reduced risk of pro-
gression of radiographic knee OA but were not protective
against incident disease in men. Further, Wluka et al.124
reported no effect of a 2-year a-tocopherol supplementation
on knee cartilage volume, measured by magnetic reso-
nance imaging. More than two decades ago, Schwartz and
collaborators126 observed that high doses of vitamin C
could limit the progression of surgically induced OA in
guinea pigs. More recently, Kurz et al.84 reported that a diet
containing vitamins C, E, A, B6 and B2 and selenium
increased the expression of antioxidant enzymes (mainly
GSH-px and Cu/Zn SOD) and decreased the incidence of
OA in STR/1N mice. In conclusion, there is no consistent
clinical evidence that antioxidant dietary or antioxidant
supplementation can prevent or slow-down cartilage deg-
radation in human joint diseases. There is no evidence that
antioxidant intake modify cartilage antioxidant status.
Additionally, there is no demonstration that a low blood or
tissue antioxidant level in human is predictive of cartilage
lesion appearance. Further, in our knowledge, there is no
study demonstrating a relationship between cartilage lesion
severity and cartilage or blood redox state.
In some of those clinical trials and animal studies,
antioxidant supplementation included vitamin C, a potent
antioxidant in vivo, that might additionally protect against
OA by stimulating collagen and proteoglycan synthesis127.
Therefore, it is difﬁcult to determine in some of the reported
studies whether the positive observed effects result from
the antioxidant properties of the supplementation or from
the stimulating effect of vitamin C on cartilage matrix
synthesis. For that reason, the importance of the antiox-
idative status of articular cartilage still remains unclear in
the clinical sense and needs further investigation.
Discussion
Chondrocytes are cells living in hypoxic conditions, as
a consequence of the absence of blood vessels in cartilage.
Although the basal metabolic functions are well adapted to
hypoxia, chondrocyte phenotype is O2 sensitive. In vitro,low O2 tension promotes the expression of the chondro-
genic phenotype and cartilage-speciﬁc matrix formation,
indicating that O2 tension is probably a key parameter in
chondrocyte culture, and particularly in the context of tissue
engineering and stem cells transplantation. Besides the
inﬂuence of O2, ROS play a crucial role in the regulation of
some normal chondrocytic activities such as cell activation,
proliferation and matrix remodeling. As long as ROS
production is under the control of the cellular antioxidant
defenses, ROS can be considered as regulatory factors of
cartilage homeostasis. However, when ROS production
exceeds the antioxidant capacities of the cell, an ‘‘oxidative
stress’’ occurs that contributes to structural and functional
cartilage damages. At this time, the role played by
‘‘oxidative stress’’ in cartilage degradation remains ques-
tionable. What are the circumstances leading to an
‘‘oxidative stress’’? When does it occur in the OA process?
Although the circumstances leading to an increase in ROS
production by chondrocytes are now well documented, the
regulation of the antioxidant activities remains obscure.
Further investigations are needed to determine the relation-
ship between antioxidant status, aging and cartilage
degradation. Is low antioxidant intake a risk factor of OA?
If yes, does its correction prevent OA progression?
Because results are not consistent, and often contradictory,
we cannot recommend for or against antioxidant adminis-
tration to treat OA. Further large clinical trials are needed to
determine the long term effects (at least three years) of
antioxidant diet, supplements or drugs on OA symptoms
and structural changes.
In conclusion, it is a major research goal for the next
decade to better understand the role played by O2 and its
derived reactive species in articular cartilage. This could
lead to major discovery in the ﬁeld of tissue engineering and
aging.
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Glossary of abbreviations
AP-1: Activating protein-1.
ATP: Adenosine triphosphate.
Coll II: Type II collagen.
Coll IX: Type IX collagen.
DNA: Deoxyribonucleic acid.
HRE: Hypoxia response elements.
GAG: Glycosaminoglycans.
GPX: Glutathione peroxidase.
H2O2: Hydrogen peroxide.
HIF-1a: Hypoxia-inducible factor-1alpha.
HOCl: Hypochlorite acid.
IFN-g: Interferon-gamma.
IGF-1: Insulin-like growth factor-1.
IL-1b: Interleukin-1beta.
LDL: Low-density lipoprotein.
LOX-1: Oxidized low-density lipoprotein receptor-1.
LPS: Lipopolyssacharides.
MMP: Metalloproteinase.
MPO: Myeloperoxidase.
NF-kB: Nuclear factor-kappaB.
NO: Nitric oxide.
NO2
: Nitrite.
NO3
: Nitrate.
NO2Cl: Nitryl chloride.
cNO2: Nitrosyl radical.
O2
c: Superoxide anion.
OA: Osteoarthritis.
OCl: Hypochlorite ion.
cOH: Hydroxyl radical.
ONOO: Peroxynitrite.
OSM: Oncostatin M.
Ox-LDL: Oxidized low-density lipoprotein.
PGE2: Prostaglandin E2.
PHD: prolyl hydroxylases.
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PRDX: Peroxiredoxin.
pVHL: von Hippel-Lindau.
RA: Rheumatoid arthritis.
RNA: Ribonucleic acid.
ROS: Reactive oxygen species.SIN-1: 3-Morpholinosydninimine.
SNAP: S-nitroso-N-acetyl-D,L-penicillamine.
SOD: Superoxide dismutase.
TGF-b: Transforming growth factor-beta.
TNF-a: Tumor necrosis factor-alpha.
VEGF: Vascular endothelial growth factor.
